“…These drugs are competitive inhibitors of hydroxymethylglutaryl-CoA reductase (HMG-CoA; EC 1.1.1.88), which catalyzes the rate-limiting step of the isoprenoid biosynthesis pathway associated with the production of cholesterol in humans and ergosterol in fungi [2]. In nature, LOV is produced by fungi from various taxonomic groups, for example, Ascomycetes, Aspergillus, Doratomyces, Gymnoascus, Hypomyces, Monascus, Paecilomyces, Penicillium, Phoma, Trichderma or basidiomycetes Lenzites, Omphalotus, Phanerochaete, Pleurotus, Trametes and many others [3][4][5]. Since, in fungi, this secondary metabolite (SM) inhibits the biosynthesis of ergosterol, which is necessary for building the cytoplasmic membrane, the fungal LOV producers should be resistant themselves to it [6,7].…”